Home Bitcoin What is Bitcoin Cash II | How BCH2 Works, Use Cases and Values
Bitcoin

What is Bitcoin Cash II | How BCH2 Works, Use Cases and Values

Share


Bitcoin Cash II (BCH2) is a SHA-256 proof-of-work cryptocurrency created through a hard fork of BC2 (BitcoinII) at block height 53,200. BCH2 inherits BC2’s complete transaction history through the fork block while adopting Bitcoin Cash consensus rules, including 32MB blocks, the ASERT difficulty adjustment algorithm, Schnorr signatures, native introspection opcodes, and protocol upgrades through Upgrade 11 (ABLA).

At the time of the fork, all BC2 holders received BCH2 at a 1:1 ratio, with approximately 2,660,000 coins distributed. BCH2 had no premine, no developer allocation, and no ICO. All new coins enter circulation exclusively through mining, following Bitcoin’s original halving schedule with a maximum supply of 21,000,000 and a current block reward of 50 BCH2.

BCH2 launched with a 1-hour ASERT half-life designed for difficulty stability on a new network. At block 92,736, the half-life automatically transitions to 2 days, matching Bitcoin Cash Node (BCHN). This transition is built into the consensus rules and requires no hard fork. SIGHASH_FORKID provides replay protection, ensuring BCH2 and BC2 transactions are independent.

The project also implements DSProof for real-time double-spend detection on unconfirmed transactions, and a witness-via-scriptSig mechanism that allows existing SegWit UTXOs from BC2’s history to be spent on the BCH2 chain. The codebase is built on BitcoinII Core v27.1 and is open source under the MIT license.



Source link

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss

Copper Property CTL Pass Through Trust Issues Monthly Reporting Package for March 2026

JERSEY CITY, N.J., April 06, 2026--(BUSINESS WIRE)--Copper Property CTL Pass Through Trust ("the Trust") has filed a Form 8-K containing its monthly report...

Celyad Oncology Reports Full Year 2025 Financial Results and Business Highlights

MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News: Celyad Oncology (Euronext: CYAD) (the “Company”), today announces its financial results for the fiscal year ended December 31, 2025,...

Related Articles

BTBG Blends Bitcoin & Gold in Stacked ETF Strategy

The era of bitcoin’s predictable four-year halving cycle is over, according to...

FLOW Cryptocurrency Investor News: If You Have Suffered

NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a...

Meme Coin ‘$SATOSHI’ Heralding the Return of Satoshi Nakamoto’s Vision Launches First Presale

Posted August 1, 2025 at 3:28 am EST. Seoul, 대한민국, August 1st,...

Is Litecoin “Dead Money” Or Is It About To Do What Solana Did In 2024?

Crypto analyst Shah has made a bullish case for Litecoin, predicting that...